Cost Effectiveness of Interferon-γ Release Assay for Tuberculosis Contact Screening in Japan
2008 · Molecular Diagnosis & Therapy · 31 citations
https://doi.org/10.1007/bf03256289
A
Akiko Kowada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
511
Citations
16
h-index
25
i10-index
Akiko Kowada is an academic researcher from Health Sciences University of Hokkaido. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Helicobacter pylori-related gastroenterology studies & Gastric Cancer Management and Outcomes. The author has an h-index of 16, co-authored 34 publications.
ORCID: 0000-0001-5200-4300Papers by this author
worksA Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening
2022 · Digestive Diseases and Sciences · 26 citations
https://doi.org/10.1007/s10620-022-07795-z
Economic and health impacts of introducing <i>Helicobacter pylori</i> eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis
2021 · Helicobacter · 25 citations
https://doi.org/10.1111/hel.12837
Dysplasia-Stratified Surveillance Identifies Optimal Strategies for Preventing Esophageal Adenocarcinoma in Barrett’s Esophagus: An Incidence-Based Cost-Effectiveness Model
2026 · medRxiv · 0 citations
https://doi.org/10.64898/2026.02.17.26346313
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat